The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...
Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...
More information: Mark Boguniewicz et al, Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities, Advances in Therapy (2024). DOI: 10.1007/s12325-024 ...
Hosted on MSN3mon
Kymera's IND Application for STAT6 Degrader Gets FDA ClearanceSanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal antibody that blocks IL-4/IL-13 signaling, is an approved therapy for multiple allergic and atopic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results